The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Virus dynamics and drug therapy
Open accessAbstract
The recent development of potent antiviral drugs not only has raised hopes for effective treatment of infections with HIV or the hepatitis B virus, but also has led to important quantitative insights into viral dynamics in vivo. Interpretation of the experimental data depends upon mathematical models that describe the nonlinear interaction between virus and host cell populations. Here we discuss the emerging understanding of virus population dynamics, the role of the immune system in limiting virus abundance, the dynamics of viral drug resistance, and the question of whether virus infection can be eliminated from individual patients by drug treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infectious Diseases of Humans: Dynamics and Control
Anderson, R. M., & May, R. M. (1991) · doi:10.1093/oso/9780198545996.001.0001 · Cited by 6,179
Self-citationRapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., & Markowitz, M. (1995) · Nature · doi:10.1038/373123a0 · Cited by 4,267
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., & Ho, D. D. (1996) · Science · doi:10.1126/science.271.5255.1582 · Cited by 3,531
Viral dynamics in human immunodeficiency virus type 1 infection
Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., et al. (1995) · Nature · doi:10.1038/373117a0 · Cited by 3,260
Self-citationHall, A. J. (1992) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(92)90276-i · Cited by 2,131
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
Coffin, J. M. (1995) · Science · doi:10.1126/science.7824947 · Cited by 1,981
Decay characteristics of HIV-1-infected compartments during combination therapy
Perelson, A. S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M., & Ho, D. D. (1997) · Nature · doi:10.1038/387188a0 · Cited by 1,880
Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., Orenstein, J. M., Kotler, D. P., & Fauci, A. S. (1993) · Nature · doi:10.1038/362355a0 · Cited by 1,808
Hepatitis B Virus Immunopathogenesis
Chisari, F. V. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.29 · Cited by 1,609
HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
Larder, B. A., Darby, G., & Richman, D. D. (1989) · Science · doi:10.1126/science.2467383 · Cited by 1,559
Embretson, J., Zupancic, M., Ribas, J. L., Burke, A., Racz, P., Tenner-Racz, K., & Haase, A. T. (1993) · Nature · doi:10.1038/362359a0 · Cited by 1,419
Population Dynamics of Immune Responses to Persistent Viruses
Nowak, M. A., & Bangham, C. R. M. (1996) · Science · doi:10.1126/science.272.5258.74 · Cited by 1,277
Self-citationBorrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-205 · Cited by 1,183
Self-citationMultiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
Larder, B. A., & Kemp, S. D. (1989) · Science · doi:10.1126/science.2479983 · Cited by 1,163
Mansky, L. M., & Temin, H. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.5087-5094.1995 · Cited by 1,154
Goulder, P. J. R., Phillips, R. E., Colbert, R. A., McAdam, S., Ogg, G., Nowak, M. A., Giangrande, P., Luzzi, G., Morgana, B., Edwards, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-212 · Cited by 1,116
Self-citationIntracellular Inactivation of the Hepatitis B Virus by Cytotoxic T Lymphocytes
Guidotti, L. G., Ishikawa, T., Hobbs, M. V., Matzke, B., Schreiber, R., & Chisari, F. V. (1996) · Immunity · doi:10.1016/s1074-7613(00)80295-2 · Cited by 1,083
Viral dynamics in hepatitis B virus infection.
Nowak, M. A., Bonhoeffer, S., Hill, A. M., Boehme, R., Thomas, H. C., & McDade, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4398 · Cited by 1,045
Self-citationHuman immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition
Phillips, R. E., Rowland-Jones, S., Nixon, D. F., Gotch, F. M., Edwards, J. P., Ogunlesi, A. O., Elvin, J. G., Rothbard, J. A., Bangham, C. R. M., Rizza, C. R., et al. (1991) · Nature · doi:10.1038/354453a0 · Cited by 1,015
A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection
Dienstag, J. L., Perrillo, R. P., Schiff, E. R., Bartholomew, M., Vicary, C., & Rubin, M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332501 · Cited by 800
Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection
Price, D. A., Goulder, P. J. R., Klenerman, P., Sewell, A. K., Easterbrook, P. J., Troop, M., Bangham, C. R. M., & Phillips, R. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1890 · Cited by 688
Zinkernagel, R. M. (1996) · Science · doi:10.1126/science.271.5246.173 · Cited by 651
Potential Mechanism for Sustained Antiretroviral Efficacy of AZT-3TC Combination Therapy
Larder, B. A., Kemp, S. D., & Harrigan, P. R. (1995) · Science · doi:10.1126/science.7542804 · Cited by 623
Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue
Haase, A. T., Henry, K., Zupancic, M., Sedgewick, G., Faust, R. A., Melroe, H., Cavert, W., Gebhard, K., Staskus, K., Zhang, Z.-Q., et al. (1996) · Science · doi:10.1126/science.274.5289.985 · Cited by 599
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy
Richman, D. D., Havlir, D., Corbeil, J., Looney, D., Ignacio, C., Spector, S. A., Sullivan, J., Cheeseman, S., Barringer, K., & Pauletti, D. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1660-1666.1994 · Cited by 576
Adaptive Evolution of Human Immunodeficiency Virus-Type 1 During the Natural Course of Infection
Wolinsky, S. M., Korber, B. T. M., Neumann, A. U., Daniels, M., Kunstman, K. J., Whetsell, A. J., Furtado, M. R., Cao, Y., Ho, D. D., Safrit, J. T., et al. (1996) · Science · doi:10.1126/science.272.5261.537 · Cited by 567
Eron, J. J., Benoit, S. L., Jemsek, J., MacArthur, R. D., Santana, J., Quinn, J. B., Kuritzkes, D. R., Fallon, M. A., & Rubin, M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332502 · Cited by 531
Antigenic Diversity Thresholds and the Development of AIDS
Nowak, M. A., Anderson, R. M., McLean, A. R., Wolfs, T. F. W., Goudsmit, J., & May, R. M. (1991) · Science · doi:10.1126/science.1683006 · Cited by 519
Self-citationSchuurman, R., Nijhuis, M., van Leeuwen, R., Schipper, P., de Jong, D., Collis, P., Danner, S. A., Mulder, J., Loveday, C., Christopherson, C., et al. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1411 · Cited by 503
Ling, R., Mutimer, D., Ahmed, M., Boxall, E. H., Elias, E., Dusheiko, G. M., & Harrison, T. J. (1996) · Hepatology · doi:10.1002/hep.510240339 · Cited by 466
Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay.
Herz, A. V., Bonhoeffer, S., Anderson, R. M., May, R. M., & Nowak, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7247 · Cited by 440
Self-citationAntigenic oscillations and shifting immunodominance in HIV-1 infections
Nowak, M. A., May, R. M., Phillips, R. E., Rowland-Jones, S., Lalloo, D. G., McAdam, S., Klenerman, P., Köppe, B., Sigmund, K., Bangham, C. R. M., et al. (1995) · Nature · doi:10.1038/375606a0 · Cited by 316
Self-citationProbabilities of sexual HIV-1 transmission
Mastro, T. D., & de Vincenzi, I. (1996) · AIDS · doi:10.1097/00002030-199601001-00011 · Cited by 282
Markowitz, M., Mo, H., Kempf, D. J., Norbeck, D. W., Bhat, T. N., Erickson, J. W., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.701-706.1995 · Cited by 226
Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes
Yang, O. O., Kalams, S. A., Rosenzweig, M., Trocha, A., Jones, N., Koziel, M., Walker, B. D., & Johnson, R. P. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.5799-5806.1996 · Cited by 219
Cheynier, R., Henrichwark, S., Hadida, F., Pelletier, E., Oksenhendler, E., Autran, B., & Wain-Hobson, S. (1994) · Cell · doi:10.1016/0092-8674(94)90417-0 · Cited by 204
Human immunodeficiency virus drug therapy and virus load
Bonhoeffer, S., Coffin, J. M., & Nowak, M. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3275-3278.1997 · Cited by 196
Self-citationHIV-1 Evolution and Disease Progression
Nowak, M. A., Anderson, R. M., Boerlijst, M. C., Bonhoeffer, S., May, R. M., McMichael, A. J., Wolinsky, S. M., Kunstman, K. J., Safrit, J. T., Koup, R. A., et al. (1996) · Science · doi:10.1126/science.274.5289.1008 · Cited by 179
Self-citationQuantitative Image Analysis of HIV-1 Infection in Lymphoid TissuePreprint
Haase, A. T., Henry, K., Zupancic, M., Sedgewick, G., Faust, R. A., Melroe, H., Cavert, W. P., Gebhard, K. H., Staskus, K., Zhang, Z., et al. (1996) · RePEc: Research Papers in Economics · Cited by 127
HIV-1: Gambling on the evolution of drug resistance?
Brown, A., & Richman, D. D. (1997) · Nature Medicine · doi:10.1038/nm0397-268 · Cited by 110
Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection
Klenerman, P., Phillips, R. E., Rinaldo, C. R., Wahl, L. M., Ogg, G. S., May, R. M., McMichael, A. J., & Nowak, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15323 · Cited by 109
Self-citationde Jong, M. D., Veenstra, J., Stilianakis, N. I., Schuurman, R., Lange, J. M. A., de Boer, R. J., & Boucher, C. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5501 · Cited by 96
HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy
Loveday, C., Kaye, S., Semple, M. G., Ayliffe, V., Tedder, R. S., Tenant‐Flowers, M., & Weller, I. V. D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92963-0 · Cited by 87
Population dynamics of HIV within an individual after treatment with zidovudine
McLean, A. R., Emery, V. C., Webster, A., et al. (1991) · AIDS · doi:10.1097/00002030-199105000-00002 · Cited by 78
Jm, C. (1996) · PubMed · Cited by 76
Nowak, M. A., Bonhoeffer, S., Loveday, C., Balfe, P., Semple, M. G., Kaye, S., Tenant‐Flowers, M., & Tedder, R. S. (1995) · Nature · doi:10.1038/375193a0 · Cited by 73
Self-citationStilianakis, N. I., Boucher, C. A., de Jong, M. D., van Leeuwen, R., Schuurman, R., & de Boer, R. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.161-168.1997 · Cited by 63
Diversity and virulence thresholds in AIDS.
de Boer, R. J., & Boerlijst, M. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.544 · Cited by 60
Anti-CD4 therapy for AIDS suggested by mathematical models
de Boer, R. J., & Boucher, C. A. (1996) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1996.0133 · Cited by 48
Antiretroviral effect of zidovudine–didanosine combination on blood and lymph nodes
Lafeuillade, A., Tamalet, C., Poggi, C., Pellegrino, P., Tourrès, C., & Izopet, J. (1997) · AIDS · doi:10.1097/00002030-199701000-00010 · Cited by 42
Richman, D. D. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90619-x · Cited by 31
Mittler, J. E., Levin, B. R., & Antia, R. (1996) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199607000-00003 · Cited by 26
Cited by
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Chun, T.-W., Stuyver, L., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A., & Fauci, A. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13193 · Cited by 1,977
Self-citationMathematical Analysis of HIV-1 Dynamics in Vivo
Perelson, A. S., & Nelson, P. W. (1999) · SIAM Review · doi:10.1137/s0036144598335107 · Cited by 1,552
Jin, X., Bauer, D. E., Tuttleton, S. E., Lewin, S., Gettie, A., Blanchard, J., Irwin, C. E., Safrit, J. T., Mittler, J., Weinberger, L., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.6.991 · Cited by 1,407
Rapin, N., Lund, O., Bernaschi, M., & Castiglione, F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009862 · Cited by 1,130
Domingo, E., Sheldon, J., & Perales, C. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05023-11 · Cited by 1,009
Metadata
- Authors
- Bonhoeffer, S., May, R. M., Shaw, G. M., & Nowak, M. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1997-06-24
- Volume
- 94
- Issue
- 13
- Pages
- 6971-6976
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2060735144
- Cited by
- 632
- References
- 52
- FWCI
- 22.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.